Close Menu
Home › Columbia U Team to Study Biocept Liquid Biopsy Platform in Breast Cancer

Columbia U Team to Study Biocept Liquid Biopsy Platform in Breast Cancer

Dec 27, 2016

NEW YORK (GenomeWeb) – Biocept said today that Columbia University Medical Center is planning a study that will evaluate its Target Selector liquid biopsy platform for detecting leptomeningeal metastases in patients with breast cancer.

LM is a condition in which cancer cells gain access to the cerebral spinal fluid, allowing them to seed metastases in the nerve tissue of the spine and brain.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
18
Featured Webinar

Clinical Genomics of NTRK Fusion Detection in Cancer

Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
19
Featured Webinar

Genome-Wide NIPT for Rare Chromosomal Conditions: Technical, Biological, and Clinical Considerations

This webinar will discuss cell-free DNA prenatal screening in the era of genome-wide sequencing and factors influencing the clinical utility of expanded noninvasive prenatal testing (NIPT) menus.

Jun
25
Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

What's Popular?

In Molecular Diagnostics

  1. USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent

  2. BGI Genomics Continues to Grow Clinical Testing Business, Add Partnerships

    Premium

  3. Bio-Techne Gets New York State Approval for Prostate Cancer Test

  4. ASCO Data Pushes Boundaries for Genomic Testing in Localized Breast Cancer

    Premium

  5. Invitae Launches Free Genetic Testing Programs With Spark Therapeutics, X4 Pharmaceuticals

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.